Conflict of interest
The authors declare no conflicts of interest concerning this article.
.
[1] Greenlee RT, Hill-Harmon MB,
Murray T, Thun M. Cancer statistics, 2001. CA: a cancer journal for
clinicians. 2001;51:15-36.
[2] Siegel R, Naishadham D, Jemal
A. Cancer statistics, 2013. CA: a cancer journal for clinicians.
2013;63:11-30.
[3] Chen P-L, Zhao T, Feng R, Chai
J, Tong G-X, Wang D-B. Patterns and Trends with Cancer Incidence and
Mortality Rates Reported by the China National Cancer Registry. Asian
Pacific Journal of Cancer Prevention. 2014;15:6327-32.
[4] Kadioglu O, Kermani NS, Kelter
G, Schumacher U, Fiebig HH, Greten HJ, et al. Pharmacogenomics of
cantharidin in tumor cells. Biochemical pharmacology. 2014;87:399-409.
[5] Liao HF, Su SL, Chen YJ, Chou
CH, Kuo CD. Norcantharidin preferentially induces apoptosis in human
leukemic Jurkat cells without affecting viability of normal blood
mononuclear cells. Food and chemical toxicology : an international
journal published for the British Industrial Biological Research
Association. 2007;45:1678-87.
[6] Twig G, Elorza A, Molina AJ,
Mohamed H, Wikstrom JD, Walzer G, et al. Fission and selective fusion
govern mitochondrial segregation and elimination by autophagy. The EMBO
journal. 2008;27:433-46.
[7] Kubli DA, Gustafsson AB.
Mitochondria and mitophagy: the yin and yang of cell death control.
Circulation research. 2012;111:1208-21.
[8] Hu ZY, Zhu XF, Zhong ZD, Sun
J, Wang J, Yang D, et al. ApoG2, a novel inhibitor of antiapoptotic
Bcl-2 family proteins, induces apoptosis and suppresses tumor growth in
nasopharyngeal carcinoma xenografts. International journal of cancer
Journal international du cancer. 2008;123:2418-29.
[9] Chan NC, Salazar AM, Pham AH,
Sweredoski MJ, Kolawa NJ, Graham RL, et al. Broad activation of the
ubiquitin-proteasome system by Parkin is critical for mitophagy. Human
molecular genetics. 2011;20:1726-37.
[10] Hanahan D, Weinberg RA. The
hallmarks of cancer. Cell. 2000;100:57-70.
[11] Fan YZ, Zhao ZM, Fu JY, Chen
CQ, Sun W. Norcantharidin inhibits growth of human gallbladder carcinoma
xenografted tumors in nude mice by inducing apoptosis and blocking the
cell cycle in vivo. Hepatobiliary & pancreatic diseases international :
HBPD INT. 2010;9:414-22.
[12] Chen YN, Chen JC, Yin SC,
Wang GS, Tsauer W, Hsu SF, et al. Effector mechanisms of
norcantharidin-induced mitotic arrest and apoptosis in human hepatoma
cells. International journal of cancer Journal international du cancer.
2002;100:158-65.
[13] Ye L, Yuan G, Xu F, Sun Y,
Chen Z, Chen M, et al. The small-molecule compound BM-1197 inhibits the
antiapoptotic regulators Bcl-2/Bcl-xL and triggers apoptotic cell death
in human colorectal cancer cells. Tumour biology : the journal of the
International Society for Oncodevelopmental Biology and Medicine.
2015;36:3447-55.
[14] Vera Y, Erkkila K, Wang C,
Nunez C, Kyttanen S, Lue Y, et al. Involvement of p38 mitogen-activated
protein kinase and inducible nitric oxide synthase in apoptotic
signaling of murine and human male germ cells after hormone deprivation.
Molecular endocrinology. 2006;20:1597-609.
[15] Edlich F, Banerjee S, Suzuki
M, Cleland MM, Arnoult D, Wang C, et al. Bcl-x(L) retrotranslocates Bax
from the mitochondria into the cytosol. Cell. 2011;145:104-16.
[16] Liu X, Kim CN, Pohl J, Wang
X. Purification and characterization of an interleukin-1beta-converting
enzyme family protease that activates cysteine protease P32 (CPP32). The
Journal of biological chemistry. 1996;271:13371-6.
[17] Rabinowitz JD, White E.
Autophagy and metabolism. Science. 2010;330:1344-8.
[18] Tormo D, Checinska A,
Alonso-Curbelo D, Perez-Guijarro E, Canon E, Riveiro-Falkenbach E, et
al. Targeted activation of innate immunity for therapeutic induction of
autophagy and apoptosis in melanoma cells. Cancer cell. 2009;16:103-14.
[19] Melser S, Lavie J, Benard G.
Mitochondrial degradation and energy metabolism. Biochimica et
biophysica acta. 2015;1853:2812-21.
[20] Beck JT, Ismail A, Tolomeo
C. Targeting the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian
target of rapamycin (mTOR) pathway: an emerging treatment strategy for
squamous cell lung carcinoma. Cancer treatment reviews. 2014;40:980-9.
[21] Guo Y, Li Y, Shan Q, He G,
Lin J, Gong Y. Curcumin potentiates the anti-leukemia effects of
imatinib by downregulation of the AKT/mTOR pathway and BCR/ABL gene
expression in Ph+ acute lymphoblastic leukemia. The international
journal of biochemistry & cell biology. 2015;65:1-11.
[22] Kumar D, Shankar S,
Srivastava RK. Rottlerin-induced autophagy leads to the apoptosis in
breast cancer stem cells: molecular mechanisms. Molecular cancer.
2013;12:171.
[23] Avalos Y, Canales J,
Bravo-Sagua R, Criollo A, Lavandero S, Quest AF. Tumor suppression and
promotion by autophagy. BioMed research international. 2014;2014:603980.
[24] Hahn-Windgassen A, Nogueira
V, Chen CC, Skeen JE, Sonenberg N, Hay N. Akt activates the mammalian
target of rapamycin by regulating cellular ATP level and AMPK activity.
The Journal of biological chemistry. 2005;280:32081-9.
[25] Copps KD, White MF.
Regulation of insulin sensitivity by serine/threonine phosphorylation of
insulin receptor substrate proteins IRS1 and IRS2. Diabetologia.
2012;55:2565-82.
[26] Shen B, He PJ, Shao CL.
Norcantharidin induced DU145 cell apoptosis through ROS-mediated
mitochondrial dysfunction and energy depletion. PloS one. 2013;8:e84610.